Black Rose Industries Limited · BSE:BLACKROSE
Black Rose Industries — Q3 FY2023 Earnings Presentation
17 slides from Black Rose Industries's earnings presentation, Feb 28, 2023
Slide 1: Black Rose Industries Ltd. Q3 FY23 Earnings Webinar
BLACK ROSE INDUSTRIES LTD. Q3 FY23 EARNINGS WEBINAR February 28, 2023 Mr. Anup Jatia – Executive Director Mr. Ambarish Daga – Joint CFO and Investor Relations Officer August 24, 2021
Slide 2: Disclaimer
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by BLACK ROSE INDUSTRIES LTD. (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendatio
Slide 3: Business presence of Black Rose
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Polyacrylamide Business presence solid - 10,000 MTPA of Black Rose Acrylamide liquid – (in R&D) N-methylol 32,000 MTPA acrylamide (NMA) - 2,000 Chemical (20,000 MTPA for merchant MTPA distribution sales and 12,000 MTPA for Chemical captive requirem
Slide 4: Financials – Profit & Loss (Standalone & Consolidated)
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Financials – Profit & Loss (Standalone & Consolidated) INR. in millions STANDALONE CONSOLIDATED Particulars Q3 FY23 Q2 FY23 Change % Q3 FY23 Q2 FY23 Change % Revenue from operations 792.97 552.76 43% 974.76 1019.42 -4% EBITDA 16.77 29.68 -43% 17.01
Slide 5: Financials – Balance Sheet (Standalone & Consolidated)
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Financials – Balance Sheet (Standalone & Consolidated) INR in millions All ratios on basis of Standalone figures STANDALONE CONSOLIDATED Return on Equity (%) Particulars Q3 FY23 Q2 FY23 Q3 FY23 Q2 FY23 10.00% Sources of Funds Equity Share Capital 5
Slide 6: Financials – (Standalone)
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Financials – (Standalone) Total revenue and EBITDA INR in millions Highlights 800 50 700 • Distribution business booked losses R 600 E in sales of acrylonitrile and E V 500 B resorcinol 29 I E N 400 796 25 T • Export of specialty monomers D U 300 5
Slide 7: Financials – Revenue and geographic mix
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Financials – Revenue and geographic mix 1% 1% MANUFACTURING 33 22 % % DISTRIBUTION 66 77 % % OTHERS Q2 FY23 Q3 FY23 19 EXPORTS % 40 % 60 % LOCAL 81 % Figures rounded off to closest unit percentage 7
Slide 8: Financials - Distribution
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Financials - Distribution Total distribution revenue and EBITDA INR in millions Highlights 650 617 40 • The overall revenue from the 575 distribution segment was up 54% from the previous quarter 500 30 R 425 E 369 E B • Domestic sales impacted due
Slide 9: Financials - Manufacturing
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Financials - Manufacturing Total manufacturing revenue and EBITDA Highlights 200 INR in millions • Overall revenues remained largely 179 176 unchanged compared to the previous quarter 150 30 • Exports of AAM-L reduced due to R E reduced year-end in
Slide 10: Acrylonitrile – Acrylamide Price Trend
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Acrylonitrile – Acrylamide Price Trend 2,600 120 2,400 100 2,150 2,200 1,970 80 2,000 1,850 ACN Price USD/MT 1,835 1,838 1,820 1,948 1,930 1,748 1,800 60 1,856 1,865 1,655 1,810 1,744 1,565 1,600 1,483 1,503 1,647 1,473 40 1,575 1,599 1,400 1,475 1
Slide 11: Outlook for the current quarter: Chemical distribution, and manufacturing
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Outlook for the current quarter: Chemical distribution, and manufacturing Chemical distribution Revenue from speciality monomers exported by the company expected to be INR 250 mn in current quarter Strong support from principal expected to boos
Slide 12: Outlook for the current quarter: Acrylamide liquid and solid
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Outlook for the current quarter: Chemical distribution, and manufacturing Acrylamide liquid and solid Increase in acrylonitrile prices in China expected to result in higher prices of acrylamide powder to help domestic sales and profitability Ov
Slide 13: Outlook for the current quarter: PAM Liquid and NMA
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Outlook for the current quarter: Chemical distribution, and manufacturing PAM Liquid N-methylol acrylamide (NMA) Demand for ceramic binder continues to be Product approvals received from domestic and weak international MNC clients Pricing con
Slide 14: Outlook for the current quarter: Polyacrylamide Solid, Polycarboxylic Acid
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Outlook for the current quarter: Chemical distribution, and manufacturing Polyacrylamide Solid Polycarboxylic Acid Guidance of R&D/technical advisor from Japan Currently in R&D phase, expecting finalization by to boost development effort and fa
Slide 15: Outlook: Focus on R&D / New Projects
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Outlook for the current quarter: Chemical distribution, and manufacturing Focus on R&D / New Projects Focus on green chemistries for production of traditional petrochemical based chemicals from bio-renewable sources Working with a principal fro
Slide 16: Manufacturing business Capacities and CAPEX
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Manufacturing business Capacities and CAPEX Product Capacity CAPEX in Rs. Incurred in Technology Further MTPA Crores* Rs. Crores* possibility MTPA Acrylamide (L) 20,000 + 41 MCI 60,000 12,000 Polyacrylamide (L) 40,000 4 In-house 40,000 NMA 2,000 <1
Slide 17: Contact
INVESTOR Q3 PRESENTATION FY23 EARNINGS WEBINAR 2020 Contact Mr. Ambarish Daga Joint CFO & Investor Relations Officer Head office 145/A, Mittal Towers Nariman Point, Mumbai 400 021, India Call / Fax +91-22-4333-7200 +91-22-2287-3022 (Fax) Mail to [email protected]
Black Rose Industries — Q3 FY2023 Earnings Presentation on 6ix